# Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

> **NCT01772940** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Saint Pierre** · enrollment: 425 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** nevirapine
- **DRUG:** ritonavir-boosted Lopinavir
- **DRUG:** Tenofovir/emtricitabine
- **DRUG:** Zidovudine/lamivudine

## Key facts

- **NCT ID:** NCT01772940
- **Lead sponsor:** Centre Hospitalier Universitaire Saint Pierre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 425 (ACTUAL)
- **Last updated:** 2013-08-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772940, "Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01772940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*